The European launch of the OMNI Ergo-Series represents a significant step for Sight Sciences in expanding its market reach and product portfolio internationally. The positive feedback from the U.S. market and the CE Mark approval under the new EU Medical Device Regulation suggest a strong potential for adoption in Europe, which could positively impact the company's revenue and growth prospects in the short term. The emphasis on improved ergonomics and precision in the product design aligns with the increasing demand for minimally invasive surgical solutions, further supporting the potential for a positive market reception.